RNA biomarkers in schizophrenia

Biomarkers for Psychiatric Disorders

Volumn , Issue , 2009, Pages 97-127

  Martins De Souza, Daniel ^a,b   Dias Neto, Emmanuel ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855455688     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-79251-4_5     Document Type: Chapter

References (128)

1. Aberg K, Saetre P, Lindholm E et al. (2006) Human QKI, a new candidate gene for schizophrenia involved in myelination. Am J Med Genet B Neuropsychiatr Genet. 141(1):84-90.
2. Aberg K, Saetre P, Jareborg N, Jazin E (2006) Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc Natl Acad Sci U S A. 103(19):7482-7487.
3. Adams MD, Dubnick M, Kerlavage AR et al. (1992) Sequence identification of 2,375 human brain genes. Nature. 355(6361):632-634.
4. Aigner L, Arber S, Kapfhammer JP et al. (1995) Overexpression of the neural growth-Associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell. 83:269-278.
5. Arai M, Amano S, Ryo A et al. (2003) Identification of epilepsy-related genes by gene expression profiling in the hippocampus of genetically epileptic rat. Brain Res Mol Brain Res. 118 (1-2):147-151.
6. Arion D, Unger T, Lewis DA (2007) Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatr. 62(7):711-721.
7. Arnold SE, Franz BR, Gur RC et al. (1995) Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatr. 152(5):738-748.
8. Aston C, Jiang L, Sokolov BP (2004) Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res. 77(6):858-866.
9. Avedissian M, Longo BM, Jaqueta CB et al. (2007) Hippocampal gene expression analysis using the ORESTES methodology shows that homer 1a mRNA is upregulated in the acute period of the pilocarpine epilepsy model. Hippocampus. 17(2):130-136.
10. Bartel DP (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116(2):281-297.
11. Bell R, Munro J, Russ C et al. (2000) Systematic screening of the 14-3-3 eta (eta) chain gene for polymorphic variants and case-control analysis in schizophrenia. Am J Med Genet. 96(6):736-743.
12. Benes FM, McSparren J, Bird ED et al. (1991) Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatr. 48(11):996-1001.
13. Ben-Shachar D, Laifenfeld D (2004) Mitochondria, synaptic plasticity, and schizophrenia. Int Rev Neurobiol. 59:273-296.
14. Ben-Shachar D, Zuk R, Gazawi H, Ljubuncic P (2004) Dopamine toxicity involves mitochondrial complex I inhibition: Implications to dopamine-related neuropsychiatric disorders. Biochem Pharmacol. 67(10):1965-1974.
15. Benton WD, Davis RW (1977) Screening lambdagt recombinant clones by hybridization to single plaques in situ. Science. 196(4286):180-182.
16. Bertucci F, Bernard K, Loriod B et al. (1999) Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. Hum Mol Genet. 8, 1715-1722.
17. Blencowe BJ (2006) Alternative splicing: New insights from global analyses. Cell. 126(1):37-47.
18. Bovenberg RA, Burbach JP, Wiegant VM et al. (1986) Gamma-Endorphin and schizophrenia: Amino acid composition of gamma-endorphin and nucleotide sequence of gamma-endorphin cDNA from pituitary glands of schizophrenic patients. Brain Res. 376(1):29-37.
19. Bowden NA, Weidenhofer J, Scott RJ et al. (2006) Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophr Res. 82(2-3):175-183.
20. Bubber P, Tang J, Haroutunian V et al. (2004) Mitochondrial enzymes in schizophrenia. J Mol Neurosci. 24(2):315-321.
21. Buratti E, Baralle M, Baralle FE (2006) Defective splicing, disease and therapy: Searching for master checkpoints in exon definition. Nucleic Acids Res. 34(12):3494-3510.
22. Cai J, Ash D, Kotch LE et al. (2005) Gene expression in pharyngeal arch 1 during human embryonic development. Hum Mol Genet. 14(7):903-912.
23. Camargo AA, Samaia HP, Dias-Neto E et al. (2001) The contribution of 700,000 ORF sequence tags to the definition of the human transcriptome. Proc Natl Acad Sci U S A. 98(21): 12103-12108.
24. Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat Rev Genet 3:285-298.
25. Chakravarty A (2003) Surrogate Markers: Their Role in Regulatory Decision Process. Food and Drug Administration. www.fda.gov/cder/Offices/Biostatistics/ Chakravarty-376/sld016.htm.
26. Cheng J, Kapranov P, Drenkow J et al. (2005) Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science. 308(5725):1149-1154.
27. Clark D, Dedova I, Cordwell S, Matsumoto I (2006) A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Mol Psychiatr. 11:459-470.
28. Clinton SM, Haroutunian V, Davis KL, Meador-Woodruff JH (2003) Altered transcript expression of NMDA receptor-Associated postsynaptic proteins in the thalamus of subjects with schizophrenia. Am J Psychiatr. 160(6):1100-1109.
29. Cowell JK, Hawthorn L (2007) The application of microarray technology to the analysis of the cancer genome. Curr Mol Med. 7(1):103-120.
30. Cuperlovic-Culf M, Belacel N, Culf AS, Ouellette RJ (2006) Microarray analysis of alternative splicing. OMICS. 10(3):344-357.
31. Dai X, Lercher LD, Clinton PM et al. (2003) The trophic role of oligodendrocytes in the basal forebrain. J Neurosci. 23(13):5846-5853.
32. Dias-Neto E, Correa RG, Verjovski-Almeida S et al. (2000) Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. Proc Natl Acad Sci U S A. 97(7): 3491-3496.
33. Dracheva S, Davis KL, Chin B et al. (2006) Myelin-Associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiol Dis. 21(3):531-540.
34. Ebersole TA, Chen Q, Justice MJ, Artzt K (1996) The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nat Genet. 12(3):260-265.
35. Frances AJ, First MB, Widiger TA et al. (1991) An A to Z guide to DSM-IV conundrums. J Abnorm Psychol 100:407-412.
36. Freedman R (2003). Schizophrenia. N Engl J Med. 349:1738-1749.
37. Giraldez AJ, Cinalli RM, Glasner ME et al. (2005) MicroRNAs regulate brain morphogenesis in zebrafish. Science. 308(5723):833-838.
38. Giros B, Sokoloff P, Martres MP et al. (1989) Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature. 342(6252):923-926.
39. Glatt SJ, Everall IP, Kremen WS et al. (2005) Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci U S A. 102(43):15533-15538.
40. Grunstein M, Hogness DS (1975) Colony hybridization: A method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A. 72(10):3961-3965.
41. Günthard HF, Wong JK, Ignacio CC et al. (1998) Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples. AIDS Res Hum Retrovir. 14(10):869-876.
42. Hakak Y, Walker JR, Li C et al. (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A. 98(8):4746-4751.
43. Hardy RJ, Loushin CL, Friedrich VL Jr et al. (1996) Neural cell type-specific expression of QKI proteins is altered in quaking viable mutant mice. J Neurosci. 16(24):7941-7949.
44. Hendriksen H, Datson NA, Ghijsen WE et al. (2001) Altered hippocampal gene expression prior to the onset of spontaneous seizures in the rat post-status epilepticus model. Eur J Neurosci. 14(9):1475-1484.
45. Hu M, Polyak K (2006) Serial analysis of gene expression. Nat Protoc. 1:1743-1760.
46. Hughes TR, Hiley SL, Saltzman AL et al. (2006) Microarray analysis of RNA processing and modification. Methods Enzymol. 410:300-16.
47. Huntsman MM, Tran BV, Potkin SG et al. (1998) Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-Amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A. 95(25):15066-15071.
48. Hyde TM, Ziegler JC, Weinberger DR (1992) Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol. 49(4):401-406.
49. Kan Z, Rouchka EC, Gish WR, States DJ (2001) Gene Structure Prediction and Alternative Splicing Analysis Using Genomically Aligned ESTs. Genome Res 11(5):889-900.
50. Kane MD, Jatkoe TA, Stumpf CR et al. (2000) Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. Nucleic Acids Res. 28, 4552-4557
51. Kao HT, Porton B, Czernik AJ et al. (1998) A third member of the synapsin gene family. Proc Natl Acad Sci U S A. 95(8):4667-4672.
52. Kapranov P, Cawley SE, Drenkow J et al. (2002) Large-scale transcriptional activity in chromosomes 21 and 22. Science. 296(5569):916-919.
53. Karry R, Klein E, Ben Shachar D (2004) Mitochondrial complex I subunits expression is altered in schizophrenia: A postmortem study. Biol Psychiatr. 55(7):676-684.
54. Katsel P, Davis KL, Haroutunian V (2005) Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: A gene ontology study. Schizophr Res. 79(2-3):157-173.
55. Kim JM, Lee KH, Jeon YJ et al. (2006) Identification of genes related to Parkinson's disease using expressed sequence tags. DNA Res. 13(6):275-286.
56. Klevering BJ, Yzer S, Rohrschneider K et al. (2004) Microarray-based mutation analysis of the ABCA4 (ABCR) gene in autosomal recessive cone-rod dystrophy and retinitis pigmentosa. Eur J Hum Genet. 12(12):1024-1032.
57. Knox DP, Skuce PJ (2005) SAGE and the quantitative analysis of gene expression in parasites. Trends Parasitol. 21:322-326.
58. Kozal MJ, Shah N, Shen N et al. (1996) Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat Med. 2(7):753-759.
59. Krichevsky AM, King KS, Donahue CP et al. (2003) A microRNA array reveals extensive regulation of microRNAs during brain development. RNA. 9(10):1274-1281. Erratum in: RNA. 2004 10(3):551.
60. Krichevsky AM, Sonntag KC, Isacson O, Kosik KS (2006) Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells. 24(4):857-864.
61. Law AJ, Kleinman JE, Weinberger DR, Weickert CS (2007) Disease-Associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet. 16(2):129-141.
62. Liston C, Miller MM, Goldwater DS et al. (2006) Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci. 26(30):7870-7874.
63. Liu X, Qin W, He G et al. (2005) A family-based association study of the MOG gene with schizophrenia in the Chinese population. Schizophr Res. 73(2-3):275-280.
64. Lockhart DJ, Dong H, Byrne MC et al. (1996) Expression monitoring by hybridization to highdensity oligonucleotide arrays. Nat. Biotechnol. 14:1675-1680.
65. Lu L, Neff F, Alvarez-Fischer D et al. (2005) Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease. Exp Neurol. 195(1):27-39.
66. Lu J, Getz G, Miska EA et al. (2005) MicroRNA expression profiles classify human cancers. Nature. 435(7043):834-838.
67. Lukiw WJ, Pogue AI (2007) Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J Inorg Biochem. 101(9):1265-1269.
68. Magic Z, Radulovic S, Brankovic-Magic M (2007) cDNA microarrays: Identification of gene signatures and their application in clinical practice. J BUON. 12 (Suppl. 1):S39-S44.
69. Makeyev EV, Zhang J, Carrasco MA, Maniatis T (2007) The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell. 27(3):435-448.
70. Margulies M, Egholm M, Altman WE et al. (2005) Genome sequencing in microfabricated highdensity picolitre reactors. Nature. 437:376-380.
71. Martorell L, Segues T, Folch G et al. (2006) New variants in the mitochondrial genomes of schizophrenic patients. Eur J Hum Genet. 14(5):520-528.
72. McCullumsmith RE, Gupta D, Beneyto M et al. (2007) Expression of transcripts for myelinationrelated genes in the anterior cingulate cortex in schizophrenia. Schizophr Res. 90(1-3): 15-27.
73. McNamara RK, Lenox RH (1997) Comparative distribution of myristoylated alanine-rich C kinase substrate (MARCKS) and F1/GAP-43 gene expression in the adult rat brain. J Comp Neurol. 379(1):48-71.
74. Mehler-Wex C, Duvigneau JC, Hartl RT et al. (2006) Increased mRNA levels of the mitochondrial complex I 75-kDa subunit. A potential peripheral marker of early onset schizophrenia? Eur Child Adolesc Psychiatr. 15(8):504-507.
75. Middleton FA, Mirnics K, Pierri JN et al. (2002) Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci. 22(7):2718-2729.
76. Middleton FA, Pato CN, Gentile KL et al. (2005) Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet B Neuropsychiatr Genet. 136(1):12-25.
77. Miller EK, Cohen JD (2001) An integrative theory of prefrontal cortex function. Annu Rev Neurosci. 24:167-202.
78. Mimmack ML, Ryan M, Baba H et al. (2002) Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a highsusceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci U S A. 99(7):4680-4685.
79. Mirnics K, Middleton FA, Marquez A et al. (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 28(1):53-67.
80. Mirnics K, Middleton FA, Lewis DA, Levitt P (2001) Analysis of complex brain disorders with gene expression microarrays: Schizophrenia as a disease of the synapse. Trends Neurosci. 8:479-486.
81. Miska EA, Alvarez-Saavedra E, Townsend M et al. (2004) Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 5(9):R68.
82. Mowry BJ, Ewen KR, Nancarrow DJ et al. (2000) Second stage of a genome scan of schizophrenia: Study of five positive regions in an expanded sample. Am J Med Genet. 96(6):864-869.
83. Nielsen KL, H gh AL, Emmersen J (2006) DeepSAGE-digital transcriptomics with high sensitivity, simple experimental protocol and multiplexing of samples. Nucleic Acids Res. 34(19): E133.
84. Noureddine MA, Li YJ, van der Walt JM et al. (2005) Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra. Mov Disord. 20(10):1299-1309.
85. Numata S, Ueno S, Iga J et al. (2007) Gene expression in the peripheral leukocytes and association analysis of PDLIM5 gene in schizophrenia. Neurosci Lett. 415(1):28-33.
86. Ouchi Y, Kubota Y, Ito C (2004) Serial analysis of gene expression in methamphetamine-And phencyclidine-Treated rodent cerebral cortices: Are there common mechanisms? Ann N Y Acad Sci. 1025:57-61.
87. Owen MJ, O'Donovan MC, Harrison PJ (2005) Schizophrenia: A genetic disorder of the synapse? BMJ 330: 158-159.
88. Ozbas-Gerçeker F, Redeker S, Boer K et al. (2006) Serial analysis of gene expression in the hippocampus of patients with mesial temporal lobe epilepsy. Neuroscience. 138(2):457-474.
89. Patino WD, Mian OY, Hwang PM (2002) Serial analysis of gene expression: Technical considerations and applications to cardiovascular biology. Circ Res. 91(7):565-569.
90. Peirce TR, Bray NJ, Williams NM et al. (2006) Convergent evidence for 2',3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch Gen Psychiatr. 63(1):18-24.
91. Perkins DO, Jeffries CD, Jarskog LF et al. (2007) microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 8(2):R27.
92. Perl O, Strous RD, Dranikov A et al. (2006) Low levels of alpha7-nicotinic acetylcholine receptor mRNA on peripheral blood lymphocytes in schizophrenia and its association with illness severity. Neuropsychobiology. 53(2):88-93.
93. Polak M, Haymaker W, Johnson JE, D'Amelio F (1982) Neuroglia and their reactions. In: Haymaker W, Adams RD (Eds) Histology and Histopathology of the Nervous System. Springfield: Charles C. Thomas.
94. Prabakaran S, Swatton JE, Ryan MM et al. (2004) Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress. Mol Psychiatr. 9(7):684-697, 643.
95. Raedler TJ, Knable MB, Weinberger DR (1998) Schizophrenia as a developmental disorder of the cerebral cortex. Curr Opin Neurobiol. 8(1):157-161.
96. Rajkowska G, Halaris A, Selemon LD (2001) Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatr. 49(9):741-752.
97. Ryu EJ, Angelastro JM, Greene LA (2005) Analysis of gene expression changes in a cellular model of Parkinson disease. Neurobiol Dis. 18(1):54-74.
98. Ryu EJ, Harding HP, Angelastro JM et al. (2002) Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci. 22(24):10690-10698.
99. Saha S, Sparks AB, Rago C et al. (2002) Using the transcriptome to annotate the genome. Nat Biotechnol. 20(5):508-512.
100. Sartorius LJ, Nagappan G, Lipska BK et al. (2006) Alternative splicing of human metabotropic glutamate receptor 3. J Neurochem. 96(4):1139-1148.
101. Schratt GM, Tuebing F, Nigh EA et al. (2006) A brain-specific microRNA regulates dendritic spine development. Nature. 439(7074):283-289; Erratum in: Nature. 2006 441(7095):902.
102. Seeman P, Chau-Wong M, Tedesco J, Wong K (1975) Brain receptors for antipsychotic drugs and dopamine: Direct binding assays. Proc Natl Acad Sci U S A. 72: 4376-4380.
103. Sidman RL, Dickie MM, Appel SH (1964) Mutant Mice (Quaking and Jimpy) with deficient myelination in the central nervous system. Science. 144:309-311.
104. Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R (2006) The involvement of ErbB4 with schizophrenia: Association and expression studies. Am J Med Genet B Neuropsychiatr Genet. 141(2):142-148.
105. Soares MB, Bonaldo MF, Jelene P et al. (1994) Construction and characterization of a normalized cDNA library. Proc Natl Acad Sci U S A. 91(20):9228-9232.
106. Sun Y, Zhang L, Johnston NL et al. (2001) Serial analysis of gene expression in the frontal cortex of patients with bipolar disorder. Br J Psychiatr (Suppl. 41):s137-s141.
107. Tennis M, Krishnan S, Bonner M et al. (2006) p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiol Biomarkers Prev. 15(1):80-85.
108. Tkachev D, Mimmack ML, Ryan MM et al. (2003) Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 362(9386):798-805.
109. Tosato S, Dazzan P, Collier D (2005) Association between the neuregulin 1 gene and schizophrenia: A systematic review. Schizophr Bull. 31(3):613-617.
110. Tsuang MT, Nossova N, Yager T et al. (2005) Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: A preliminary report. Am J Med Genet B Neuropsychiatr Genet. 133(1):1-5.
111. Uranova N, Orlovskaya D, Vikhreva O et al. (2001) Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 55, 597-610.
112. Usiello A, Baik JH, Rouge-Pont F et al. (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature. 408(6809):199-203.
113. Van Bogaert P, Azizieh R, Désir J et al. (2007) Mutation of a potassium channel-related gene in progressive myoclonic epilepsy. Ann Neurol. 61(6):579-586.
114. Vawter MP, Barrett T, Cheadle C et al. (2001) Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull. 55(5):641-650.
115. Vawter MP, Frye MA, Hemperly JJ et al. (2000) Elevated concentration of N-CAM VASE isoforms in schizophrenia. J Psychiatr Res. 34(1):25-34.
116. Vawter MP, Crook JM, Hyde TM et al. (2002) Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: A preliminary study. Schizophr Res. 58(1):11-20.
117. Vawter MP, Ferran E, Galke B et al. (2004) Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr Res. 67(1):41-52.
118. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW (1995) Serial analysis of gene expression. Science. 270:484-487.
119. Vo N, Klein ME, Varlamova O et al. (2005) A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A. 102(45):16426-16431; Erratum in: Proc Natl Acad Sci U S A. 2006 17;103(3):825.
120. Wan C, Yang Y, Feng G et al. (2005) Polymorphisms of myelin-Associated glycoprotein gene are associated with schizophrenia in the Chinese Han population. Neurosci Lett. 388(3): 126-131.
121. Wang SM (2007) Understanding SAGE data. Trends Genet. 23(1):42-50.
122. Xi ZR, Qin W, Yang YF et al. (2004) Transmission disequilibrium analysis of the GSN gene in a cohort of family trios with schizophrenia. Neurosci Lett. 372(3):200-203.
123. Xu R, Hranilovic D, Fetsko LA et al. (2002) Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. Mol Psychiatr. 7(10):1075-1082.
124. Xu PT, Li YJ, Qin XJ et al. (2007) A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allelespecific gene expression in hippocampus in Alzheimer disease. Mol Cell Neurosci. 36(3):313-331.
125. Yao JK, Reddy RD, van Kammen DP (2001) Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications. CNS Drugs. 15(4):287-310.
126. Zaidel DW, Esiri MM, Harrison PJ (1997) Size, shape, and orientation of neurons in the left and right hippocampus: Investigation of normal asymmetries and alterations in schizophrenia. Am J Psychiatr. 154(6):812-818.
127. Zhang B, Farwell MA (2007) microRNAs: A new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med. 12:3-21.
128. Zhao C, Xu Z, Chen J et al. (2006) Two isoforms of GABA(A) receptor beta2 subunit with different electrophysiological properties: Differential expression and genotypical correlations in schizophrenia. Mol Psychiatr. 11(12):1092-1105.